M Ding, R Shi, F Fu, M Li, D De, Y Du, Z Li - Journal of Advanced Research, 2023 - Elsevier
Introduction The anti-cancer medication doxorubicin (Dox) is largely restricted in clinical
usage due to its significant cardiotoxicity. The only medication approved by the FDA for Dox …